Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
If it involves an employer or a consumer, disproportionate.
We’re fighting Wall Street. Think proportionately, if not fractionally.
Has AVC reviewed your work? I don’t see 8/1 in there anywhere.
A woman on the radio talks about revolution
When it's already passed her by
Watching the world wake up from history
Well, until 8/1. Then I’ll have to find something else to do.
ILT, I agree,
But to the point of your subsequent question, the 8/1 drumbeat is to the tune of an unannounced 4/1 submission.
I’m of the belief that the company announces acceptance if not submission first. I am happy to be proven wrong tomorrow, 7/31, and any day in between.
Maybe on the 6.00000-year anniversary of my first purchase. Which will be 7/14.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=171494781
“… today's MIA manufacturing certificate puts NWBO on the road to commercial approval in the U.K by 8/1/23,..”
Thanks ATL. I think chitgpt just hangs out in the library longer, bangs on the dewey decimal system a little harder, and is finished in a matter of microseconds, which I think is faster than most people I know.
Will chatgpt cite sources when asked?
Bosch Smile Indicator.
Like the Greenspan Briefcase Indicator. But once a year.
Throw us a bone!
“L” is for Liau.
DCVax-Liau.
Some have postulated it is also derived in part from the second letter of Dr. Boynton’s name. (First name)
Let him sleep on it, he’ll give you his answer in the morning.
Re IMGN, if you know of any longs who may have some capital gains to realize and deploy elsewhere, I know of a company with a promising therapeutic cancer vaccine platform.
Just listened to a podcast, was memorable hearing LL use “DCVax”. Repeatedly.
Ashkan describes differentiation in the trial as using IL-4 and GM-CSF. Can the maturation agent be replaced like that simply because it’s in a patent?
Still finding this hard to believe.
Would that not be like saying when L is approved it will be for clean room production (as in the trial) and for Flaskworks.
Back to peptides? I thought Lysate had been proven more effective.
Pay attention people. That’s not Joe speaking. That’s Joe copying and Joe pasting.
Here is my contribution…
“External Real World Evidence from patient data already exists! This MUST be used as the “control arm” in clinical trials.... INSTEAD of sacrificing any more people from this patient population to placebos instead of TREATMENT.Joe Pratt -610 517 4445”
Dang it.
AP Writer is on it. She is turning the thumbscrews on CM because of their failure to rescue the share price. OTOH, she suggests Lappin was murdered by those who don’t want to see DCVax come to market. OTOOH, JP has not posted that tweet to iHub and then tweeted the iHub post about a tweet back to twitter. So we are not quite sure what to make of it at this point. But I’m thinking about putting it all behind my own paywall and making some coin that way.
All is well. You know, as in the Animal House parade scene.
Or maybe the Blues Brothers scene where Bluto tries to cheer up Flounder after the road trip with Flounder’s brother’s car.
Precisely.
C’mon in. The water is warm.
Yes. Better yet, have an employer fund one using newly obsolete devices. ISR2900-series routers, for example.
Hands on experience. Surround yourself with greatness. Be a knowledge sponge. Always willingly accept (and seek out) more. Take the test(s), find out where you are, take again if needed.
Google “pull swipe detector”. Defendant Citadel knows when spoofing occurs. Chooses when and how they want to act on it.
“267… Their algorithms were programmed to, and did, generate trading patterns…”
How would they know this? Or are they just claiming anecdotally…. Or that logic dictates. Or that the dots can be connected.
https://www.cohenmilstein.com/professional/raymond-m-sarola
Fairly certain the CM team was three. Mr Sarola has been added as the fourth.
Whistleblower? I wonder if there is one on our case and if maybe Cohen-M has a whistleblower specialist and if maybe he is on the case team.
Hmmm…
Redacted
I think the MHRA website updater has been reassigned to do inspections and now updates the website only on school nights after the kids are asleep, and between seasons of whatever their favorite Netflix series happens to be.
Doc, let me help you along in your DD on this one. As is usually the case one will need to focus on what was said to understand what was not said, and then draw a bunch of conclusions from the missing facts.
The key word here is “shoe”, singular. Shoes usually come in pairs. While some might immediately conclude flip is an amputee, others might conclude that he just got a good deal on a single shoe. Does he go without on the other foot? Does he wear a shoe of a different brand or style on the other foot? Was that other shoe acquired in a similar manner? Does this tell us anything about who he procures his shoes from? He must have more than one source, I would think.
Or, going down a different path, maybe someone else is tying the other shoe. What can we read into that possibility?
(With humblest apologies if I have offended anyone)
“…or did you forget…”
Oh no, not again!
Re: ae aka joe Pratt aka Whatever Capital
It appears, based on Mav_1’s post this morning that ae lifted the information from Bio9999 without attributing it to him.
Not unusual.
Curious, do you know what a Codian MSE 8510 is?
It wasn’t a Twitter breakup. One party does not announce they are blocking the other. I doubt there is much that prevents BMY from coming back to the table. Or NWBO, someday, for that matter. But if there is an acquisition by someone with a PD-1 inhibitor, the others will be left to find their own novel therapies.
Dr Bala, I will second that!!!
All in favor say “aye”.
Motion carried!!!
@RemindMeOfThis in 3 months.
Yeah, so van den Bent reviewed Preusser’s work.
Then, for an extra layer of peer-reviewedry, Preusser reviews van den Bent’s review of his work.
And then, get this, van den Bent reviews Preusser’s review of his review of his work.
That, I am sure, is what Dr Feuerstein is privy to.